GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiuzhitang Co Ltd (SZSE:000989) » Definitions » Net-Net Working Capital

Jiuzhitang Co (SZSE:000989) Net-Net Working Capital : ¥0.46 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Jiuzhitang Co Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Jiuzhitang Co's Net-Net Working Capital for the quarter that ended in Mar. 2025 was ¥0.46.

The industry rank for Jiuzhitang Co's Net-Net Working Capital or its related term are showing as below:

SZSE:000989's Price-to-Net-Net-Working-Capital is ranked worse than
77.78% of 405 companies
in the Drug Manufacturers industry
Industry Median: 7.77 vs SZSE:000989: 19.57

Jiuzhitang Co Net-Net Working Capital Historical Data

The historical data trend for Jiuzhitang Co's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiuzhitang Co Net-Net Working Capital Chart

Jiuzhitang Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.25 0.45 0.40 0.30

Jiuzhitang Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 -0.27 0.07 0.30 0.46

Competitive Comparison of Jiuzhitang Co's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Jiuzhitang Co's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiuzhitang Co's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiuzhitang Co's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Jiuzhitang Co's Price-to-Net-Net-Working-Capital falls into.


;
;

Jiuzhitang Co Net-Net Working Capital Calculation

Jiuzhitang Co's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net-Net Working Capital(A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(892.88+0.75 * 392.917+0.5 * 1061.844-1263.51
-0-194.719)/855.942
=0.30

Jiuzhitang Co's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2025 is calculated as

Net-Net Working Capital(Q: Mar. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(945.223+0.75 * 686.277+0.5 * 909.479-1318.379
-0-200.066)/855.942
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Jiuzhitang Co  (SZSE:000989) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Jiuzhitang Co Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Jiuzhitang Co's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiuzhitang Co Business Description

Traded in Other Exchanges
N/A
Address
No. 339 Tongzipo West Road, Tonglu, Hunan province, Changsha, CHN, 410205
Jiuzhitang Co Ltd is a China-based medicine company. It is engaged in the manufacture and sale of traditional Chinese medicines and biological medicine. The company developed four different lines of products such as Health Products, Modern Chinese Medicine, Ecological Western Medicine and Biomedical Medicine. The organization sells its products in China and international countries.
Executives
Li Zhen Guo Director
Liu Guo Chao Director
Xu Xiang Ping Directors, executives
Liu Shu Xia Supervisors
Sun Wei Xiang Executives
Sheng Suo Zhu Directors, executives
Yang Lian Min Executives
Gao Jin Yan Executives
Sun Xiao Bo Director
Xu De An Supervisors
Cai Guang Yun Executives
Yu Ke Jian Director

Jiuzhitang Co Headlines

No Headlines